Advanzeon Solutions, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHCR research report →
Price Chart
About the company
Advanzeon Solutions, Inc. operates the SleepMaster Solutions program, an initiative focused on managing sleep apnea, delivered via its subsidiary, Pharmacy Value Management Solutions, Inc. The company, which dates back to its founding in 1969 and maintains its headquarters in Tampa, Florida, previously operated as Comprehensive Care Corporation until it was rebranded as Advanzeon Solutions, Inc.
- CEO
- Clark A. Marcus
- IPO
- 1975
- Employees
- 2
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on CHCR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.24
- RSI (14)
- 10
- Avg Volume
- 10.95K
No earnings-call transcripts are available for CHCR yet.
- Free Float
- 99.7%
- Shares Outstanding
- 119.91M
- Float Shares
- 119.57M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 26, 20 | Kreitzer Stephen M. | buy | 200,000 |
| Jan 28, 21 | Marcus Clark A. | buy | 140,000 |
| Jan 28, 21 | Marcus Clark A. | buy | 0 |
| Jan 20, 21 | Marcus Clark A. | buy | 40,000 |
| Jan 20, 21 | Marcus Clark A. | buy | 0 |
| Sep 14, 20 | Kreitzer Stephen M. | buy | 82,857 |
| May 13, 20 | SUBIN NEIL S | other | 0 |
| May 13, 20 | SUBIN NEIL S | other | 0 |
| May 13, 20 | SUBIN NEIL S | other | 0 |
| May 13, 20 | SUBIN NEIL S | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CHCR coverage
Recent articles, reports, and earnings notes.
No research on CHCR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHCR report →